20992 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Neuropeptide Y
Compositions for Use in the Treatment of Diabetes or Obesity
#2A PHARMACEUTICALLY ACCEPTABLE AQUEOUS GEL COMPOSITION FOR MRNA DELIVERY
#3COMBINATION THERAPY COMPRISING LONG ACTING GLP-1/GLUCAGON AND NPY2 RECEPTOR AGONISTS
#4Treatment of Mood and Anxiety Disorders
#5RECEPTOR-TARGETING PEPTIDE-DRUG CONJUGATES
#6INTRANASAL NEUROPEPTIDES FOR USE IN STRESS-RELATED IMPAIRMENTS
#7Method of Delivering a Centrally-Acting Peptide Derivative, and Method of Treating a Neuropsychiatric Disorder
#8NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATING AN ANTI-CANCER IMMUNE RESPONSE
#9Acylated glucagon analogue
#10System for the transdermal delivery of active ingredient
#11METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES
#12NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATING AN ANTI-CANCER IMMUNE RESPONSE
#13METHODS AND COMPOSITIONS FOR THE MODULATION OF BETA-ENDORPHIN LEVELS
#14NEUROPEPTIDE Y-DERIVED PEPTIDES
#15Coagonists of glucagon-like peptide 1 receptor and neuropeptide Y2 receptor
#16Acylated glucagon analogue
#17Systems and methods for delivery of peptides
#18Peptides for treating bone diseases and use thereof
#19Method using an Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury
#20Composition containing neuropeptide Y for inhibiting side effects of anticancer agents
#21METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS
#22Methods and compositions for managing reproduction
#23Peptides for preventing or treating bone diseases and use thereof
#24Compositions and methods for affecting mood states
#25Neuropeptide analogs, compositions, and methods for treating pain
#26MODIFICATION OF FEEDING BEHAVIOR
#27System for the transdermal delivery of active ingredient
#28PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT BY NASAL ADMINISTRATION OF PATIENTS SUFFERING FROM ANXIETY AND SLEEP DISORDERS
#29Pharmaceutical composition for preventing or treating osteoporosis which comprises neuropeptide Y as active ingredient
#30Systems and methods for delivery of peptides
#31Compositions and methods for affecting mood states
#32Methods and compositions for delivering active agents with enhanced pharmacological properties
#33Neuropeptide Y-derived peptides
#34CONJUGATION OF PHARMACEUTICALLY ACTIVE AGENTS WITH TRANSTHYRETIN LIGANDS THROUGH ADJUSTABLE LINKERS TO INCREASE SERUM HALF-LIFE
#35Dual GLP-1/glucagon receptor agonists derived from exendin-4
#36Oral administration of tocilizumab treatment of autoimmune disease
#37NOVEL HEMOSTATIC PATCH AND USES THEREOF
#38Systems and methods for delivery of peptides
#39Compositions and methods for affecting mood states
#40PEPTIDE YY AND PEPTIDE YY AGONISTS FOR TREATMENT OF METABOLIC DISORDERS
#41Method for suppressing receptor tyrosine kinase-mediated pro-survival signaling in cancer cell
#42Neuropeptide Y treatment of autoimmune disease
#43Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders
#44Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#45NOVEL RETRO-INVERSO LEPTIN PEPTIDE ANTAGONISTS
#46COMPOSITIONS COMPRISING CYCLIC AMP ENHANCERS AND/OR EP LIGANDS, AND METHODS OF PREPARING AND USING THE SAME
#47MODIFICATION OF FEEDING BEHAVIOUR
#48Analogues of Neuropeptide Y Having Proline Substitution At Position 34
#49INTESTINAL TREATMENT
#50Methods for Treating Obesity Related Disease
#51Method and compositions for prevention and treatment of diabetic and aged skin
#52MODIFICATION OF FEEDING BEHAVIOUR
#53Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease
#54Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#55Neoropeptide-2-Receptor (Y-2R) Agonists
#56Compositions And Methods For Lipo Modeling
#57USE OF NEUROPEPTIDE Y (NPY) AND AGONISTS AND ANTAGONISTS THEREOF FOR TISSUE REGENERATION
#58Y2 Selective Receptor Agonists for Therapeutic Interventions
#59Dipeptidyl peptidase IV inhibitors for the treatment of schizophrenia and depression
#60Conjugate of insulin and vitamin B12 for oral delivery
#61Aryl ketone compounds and compositions for delivering active agents
#62Modification of feeding behaviour
#63METHODS FOR ENHANCED EPITHELIAL PERMEATION OF Y2 RECEPTOR-BINDING PEPTIDES FOR TREATING AND PREVENTING OBESITY
#64COMPOSITIONS FOR ENHANCED EPITHELIAL PERMEATION OF Y2 RECEPTOR-BINDING PEPTIDES
#65Methods for treating irritable bowel syndrome
#66COMPOSITIONS AND METHODS FOR ENHANCED MUCOSAL DELIVERY OF PYY PEPTIDE
#67Dipeptidyl peptidase IV inhibitors for the treatment of anxiety
#68Methods for manipulating satiety
#69Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging
#70Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
#71Modification of feeding behaviour
#72Modulation of the neuroendoctrine system as a therapy for motor neuron disease
#73Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#74Use of neuropeptides for ligament healing
#75Modification of feeding behavior using PYY and GLP-1
#76Use of inhibitors of the y2 receptor of neuropeptide y in the treatment of alcoholism
#77Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
#78Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity